Speakers

Jason Bergsbaken, James Ford, Judith Smith

Jason Bergsbaken, PharmD, BCOP

Jason Bergsbaken, PharmD, BCOP
Pharmacy Coordinator, Regional Oncology Services
University of Wisconsin Hospital and Clinics
Madison, WI

Dr. Bergsbaken currently serves as Pharmacy Coordinator, Regional Oncology Services for UW Health in Madison, WI. His responsibilities include the coordination and standardization of pharmaceutical care among UW Carbone Cancer Center partners. Dr. Bergsbaken received his Doctor of Pharmacy degree from the University of Wisconsin-Madison. Following graduation, he completed a PGY1 Pharmacy Practice Residency and PGY2 Oncology Pharmacy Residency at UW Health. In addition to his coordinator responsibilities, Dr. Bergsbaken practices as an Oncology Clinical Pharmacist across UW Health adult care settings, including University Hospital (inpatient hematology/oncology/BMT), UW Carbone Cancer Center (ambulatory/clinic), and UW Oncology Pharmacy (community). Additionally, he has been intimately involved with the implementation of multiple practice advancement initiatives, including pharmacist-led oral chemotherapy management. Current professional affiliations include American Society of Health-System Pharmacists (ASHP), Hematology/Oncology Pharmacy Association (HOPA), and Pharmacy Society of Wisconsin (PSW).

Back to top

James Ford, MD

Professor of Medicine and Genetics
Director, Stanford Program for Clinical Cancer Genomics
Division of Oncology
Stanford University School of Medicine
Stanford, CA

Dr. Ford is a Medical Oncologist and Geneticist at Stanford, devoted to studying the genetic basis of breast and GI cancer development, treatment and prevention in families and populations. He graduated in 1984 from Yale University where he later received his MD from the School of Medicine in 1989. He was an Internal Medicine resident and Oncology fellow at Stanford, and joined the faculty in 1998. He is currently Professor of Medicine (Oncology) and Genetics, and Director of the Stanford Cancer Genetics Clinic and the Cancer Genomics Program at the Stanford University Medical Center in Stanford, CA.

Dr. Ford’s clinical interests include the diagnosis and treatment of patients with a hereditary pre-disposition to cancer. He runs the Stanford Cancer Genetics Clinic, that sees patients for genetic counseling and testing of hereditary cancer syndromes for prevention and early diagnosis of cancer in high-risk individuals and populations. He has recently been named the Director of Stanford’s new Cancer Genomics Program, performing next-generation tumor profiling to identify novel genetic targets for personalized targeted therapies, and directs the Molecular Tumor Board.

Dr. Ford is an editor of numerous scientific journals, including Cancer Research, DNA Repair, and PLoS Genetics. He has recently been named the founding Editor-in-Chief of JCO Precision Oncology.

Back to top

Judith Smith, PharmD, BCOP, CPHQ, FCCP, FISOPP

Associate Professor
Director, Women’s Health Integrative Medicine Research
Program
McGovern Medical School
The University of Texas Health Science Center at Houston
Houston, TX

Dr. Smith is an Associate Professor in the Department of Obstetrics, Gynecology and Reproductive Sciences at The UTHSC McGovern Medical School and Director of the Women’s Health Integrative Medicine Program in Houston, TX. She also has faculty appointments at the University of Houston College of Pharmacy, UTHealth School of Nursing, and the UTHSC‐Houston Graduate School of Biomedical Sciences. Dr. Smith received a Bachelor of Science in Pharmacy and her Doctor of Pharmacy degree from Union University Albany College of Pharmacy. She completed residency in Pharmacy Practice and Oncology Pharmacy Practice at the National Institutes of Health followed by a fellowship in Clinical Pharmacology at University of Texas MD Anderson Cancer Center. Upon completion of her fellowship, she joined the Faculty in the Department of Gynecologic Oncology at UT MD Anderson Cancer Center and in 2003 joined the faculty of UTHealth McGovern Medical School part‐time until 2014 when she transitioned into her current fulltime appointment. She is Board Certified in Oncology Pharmacy and a Certified Professional in Healthcare Quality. Her research focus is to advance the progress of the safe and effective use of nutritional and herbal supplements with pharmacologic modalities as it relates to women’s health and cancer.

Back to top